Efficacy of Oral Apremilast in the Treatment of Alopecia Areata at the Tertiary Care Hospital, Karachi.
Condition:   Alopecia Areata Intervention:   Drug: Apremilast 30mg Sponsor:   Jinnah Postgraduate Medical Centre Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 3, 2023 Category: Research Source Type: clinical trials

A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss (SCALP2)
Condition:   Alopecia, Androgenetic Interventions:   Drug: Clascoterone 5% solution;   Drug: Vehicle solution Sponsors:   Cassiopea SpA;   Ergomed PLC;   Pharmapace Inc;   Canfield Scientific Inc.;   ICON Clinical Research Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2023 Category: Research Source Type: clinical trials